1. Home
  2. ANGH vs ALGS Comparison

ANGH vs ALGS Comparison

Compare ANGH & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

SELL

Current Price

$3.40

Market Cap

33.8M

ML Signal

SELL

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$5.02

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGH
ALGS
Founded
2012
2018
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
34.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ANGH
ALGS
Price
$3.40
$5.02
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $52.38
AVG Volume (30 Days)
4.4K
★ 37.9K
Earning Date
04-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.30
EPS
★ N/A
N/A
Revenue
N/A
★ $2,186,000.00
Revenue This Year
$251.30
$1,562.10
Revenue Next Year
$26.67
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.25
$3.98
52 Week High
$7.89
$13.69

Technical Indicators

Market Signals
Indicator
ANGH
ALGS
Relative Strength Index (RSI) 44.05 37.04
Support Level $3.09 $4.97
Resistance Level $3.89 $6.91
Average True Range (ATR) 0.16 0.33
MACD -0.04 -0.01
Stochastic Oscillator 31.03 3.57

Price Performance

Historical Comparison
ANGH
ALGS

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. The Group's three reportable segments: Revenue from subscriptions, Revenue from advertisement, and Revenue from live events. It generates the majority of its revenue from subscriptions segment, which is comes from subscription fees. The advertisement revenue segment generated through the sale of advertising across the Group's content. Revenues from live events are generated from the sale of tickets, food and beverage & sponsorship. It derives maximum revenue from KSA.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: